U.S. Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Eli Lilly

Market Cap: US$853.0b

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$581.2b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

AbbVie

Market Cap: US$374.3b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$304.2b

Operates as a healthcare company worldwide.

Amgen

Market Cap: US$188.8b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Gilead Sciences

Market Cap: US$175.7b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Vertex Pharmaceuticals

Market Cap: US$113.6b

Operates as a biotechnology company in the United States, Europe, and internationally.

Zoetis

Market Cap: US$50.5b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Alnylam Pharmaceuticals

Market Cap: US$43.4b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Teva Pharmaceutical Industries

Market Cap: US$35.5b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Waters

Market Cap: US$31.2b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Natera

Market Cap: US$29.9b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

IQVIA Holdings

Market Cap: US$29.0b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Elanco Animal Health

Market Cap: US$11.7b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Revvity

Market Cap: US$10.1b

Provides health sciences solutions, technologies, and services.

Vaxcyte

Market Cap: US$8.9b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Bio-Techne

Market Cap: US$8.6b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Qiagen

Market Cap: US$8.5b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

Bio-Rad Laboratories

Market Cap: US$7.6b

Develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.

Repligen

Market Cap: US$6.8b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Caris Life Sciences

Market Cap: US$5.5b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Avantor

Market Cap: US$5.4b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Sotera Health

Market Cap: US$4.3b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Ligand Pharmaceuticals

Market Cap: US$4.1b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

10x Genomics

Market Cap: US$2.9b

Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.

Veracyte

Market Cap: US$2.6b

Operates as a diagnostics company in the United States and internationally.

Disc Medicine

Market Cap: US$2.5b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

Adaptive Biotechnologies

Market Cap: US$2.3b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Zymeworks

Market Cap: US$2.0b

A biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases.

Azenta

Market Cap: US$1.0b

Provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

BioLife Solutions

Market Cap: US$952.0m

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

MannKind

Market Cap: US$804.1m

A biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.

Gyre Therapeutics

Market Cap: US$647.4m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

Mesa Laboratories

Market Cap: US$519.2m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

AVITA Medical

Market Cap: US$126.2m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Aldeyra Therapeutics

Market Cap: US$94.5m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.